Sunday, December 11, 2022 7:45:09 AM
This is what also probably caused delays along with labeling/supply issues back in March. New international product, an immune modulator, during the pandemic, I'm sure drew a lot of scrutiny from the FDA. Looks like the issues have been resolved and they are ready to launch on Monday.
Lots of talk about it only being on Onelavi.com, but this is just the initial launch imo, and as time goes by and they can assess demand, they will hopefully grow into other retailers and markets.
Supplement market was never initially on the radar, but it's a huge market and it can hopefully generate revenue until they can profit from ITV-1 or Clone 3. Any revs will certainly be welcomed.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
FEATURED ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • Jul 30, 2024 8:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • BLOZF • Jul 29, 2024 9:07 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM